The p38α MAPK–MK2 axis drives chemotherapy-mediated nuclear actin remodeling to promote ovarian cancer progression
Year: 2026
Type: article
Abstract: Nuclear F-actin facilitates DNA damage repair and contributes to cancer chemoresistance. However, the regulatory mechanisms controlling its dynamic polymerization in response to genotoxic stress remain poorly defined. A major barrier in nuclear actin research is the lack of tools for precise, high-throughput analysis. To systematically investigate nuclear F-actin assembly in DNA damage response, we developed a deep learning pipeline, named nFANet, for high-throughput detection and analysis of nuclear F-actin. Here, using ovarian cancer-a malignancy where chemoresistance is a major clinical obstacle-as a model, we showed that platinum-based chemotherapy robustly induces nuclear F-actin assembly. A subsequent kinome screening, in combination with the application of nFANet, identified the kinase p38α MAPK as a critical upstream regulator of platinum-induced nuclear F-actin assembly. Mechanistically, the p38α MAPK-MK2 signaling pathway promotes formin-mediated nuclear F-actin assembly in response to chemotherapy. Importantly, pharmacological inhibition or genetic knockout of the p38α MAPK-MK2 pathway sensitized ovarian cancer cells to platinum-based therapy. Our work uncovers a key mechanism governing nuclear actin remodeling under genotoxic stress and lays the foundation for identifying a patient subgroup likely to benefit from therapeutic targeting of this pathway.
Institutions: Fudan University, Zhongshan Hospital, Zhejiang University, Westlake University, Second Affiliated Hospital of Zhejiang University, Shanghai Jiao Tong University, Renji Hospital, Shanghai Key Laboratory of Gynecologic Oncology, MRC Weatherall Institute of Molecular Medicine, Medical Research Council
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: hybrid
Awards: G3451912116, G9001343751
OpenAlex ID: W7225909592
